Old Web
English
Sign In
Acemap
>
authorDetail
>
Dunja Klein
Dunja Klein
Medicine
Renal cell carcinoma
Internal medicine
Interim
Pazopanib
4
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial.
2020
International Journal of Cancer
Michael Staehler
Michael Stöckle
Daniel C. Christoph
Arnulf Stenzl
Karin Potthoff
Marc-Oliver Grimm
Dunja Klein
Johanna Harde
Fabian Brüning
Peter J. Goebell
Marinela Augustin
Frederik C. Roos
Iris Benz-Rüd
Norbert Marschner
Viktor Grünwald
Show All
Source
Cite
Save
Citations (1)
Sequential treatment with pazopanib (PAZO) followed by nivolumab (NIVO) in patients with advanced or metastatic renal cell carcinoma (mRCC): Third interim results of the non-interventional study PAZOREAL.
2019
Journal of Clinical Oncology
Martin Boegemann
Jens Bedke
Martin Schostak
Christiane Hering-Schubert
Manfred Welslau
J. Schleicher
Thomas Wolf
Alexander Petzoldt
Christian Doehn
Carsten Grüllich
Viktor Grünwald
Thomas Steiner
Anja Rogler
Sven Hanson
Dunja Klein
Tanja Medinger
P. J. Goebell
Show All
Source
Cite
Save
Citations (1)
Effectiveness and safety of pazopanib (PAZO) and everolimus (EVE) in a changing treatment (Tx) landscape: Interim results of the non-interventional study PAZOREAL.
2018
Journal of Clinical Oncology
Martin Boegemann
Jens Bedke
Martin Schostak
Manfred Welslau
Christiane Hering-Schubert
Thomas A. Wolf
J. Schleicher
Alexander Petzold
Christian Doehn
Carsten Grüllich
Viktor Grünwald
Thomas Steiner
Rainer Ehness
Dunja Klein
Tanja Medinger
P. Goebell
Show All
Source
Cite
Save
Citations (0)
Telomeraseaktivitätsmessung mittels Real- Time PCR zur Differenzierung benigner und maligner Liquorpleozytosen
2014
Dunja Klein
Show All
Source
Cite
Save
Citations (0)
1